Insider Transactions in Q1 2025 at Adaptive Biotechnologies Corp (ADPT)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 20
2025
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
99,107
-3.7%
|
$792,856
$8.44 P/Share
|
|
Feb 20
2025
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
99,107
+3.57%
|
$594,642
$6.32 P/Share
|
|
Feb 19
2025
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
186,080
-6.74%
|
$1,488,640
$8.46 P/Share
|
|
Feb 19
2025
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
186,080
+6.31%
|
$1,116,480
$6.32 P/Share
|
|
Feb 18
2025
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
211,160
-7.57%
|
$1,689,280
$8.5 P/Share
|
|
Feb 18
2025
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
211,160
+7.04%
|
$1,266,960
$6.32 P/Share
|
|
Feb 14
2025
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
158,921
-5.81%
|
$1,271,368
$8.46 P/Share
|
|
Feb 14
2025
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
158,921
+5.49%
|
$953,526
$6.32 P/Share
|
|
Feb 13
2025
|
Chad M Robins CEO and Chairman |
SELL
Open market or private sale
|
Direct |
100,287
-3.75%
|
$802,296
$8.44 P/Share
|
|
Feb 13
2025
|
Chad M Robins CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
100,287
+3.61%
|
$601,722
$6.32 P/Share
|